文献速递肾小球疾病慢性肾脏病急性肾损伤

儿童起病狼疮性肾炎的肾脏应答状态与长期肾脏结局

Renal Response Status and Long-Term Kidney Outcomes in Childhood-Onset Lupus Nephritis.
PubMed 文献 · Kidney Int Rep · 2025-11-26

结果显示24个月mPERR应答者无晚期CKD生存率更优,mPERR无应答和基线eGFR<60是CKD 4-5D/T的预测因素,mPERR和mCRR无应答均与肾脏复发风险升高相关。

要点

  • 活检后24个月mPERR应答可预测儿童狼疮性肾炎长期肾脏存活。
  • 24个月mPERR无应答者进展至CKD 4-5D/T风险显著增加。
  • 24个月mPERR和mCRR无应答均与肾脏复发风险升高相关。

核心结论

  • 活检后24个月mPERR可预测儿童起病狼疮性肾炎的长期肾脏存活。
  • 达到mPERR和mCRR与降低肾脏复发风险显著相关。

研究设计与样本

  • 前瞻性数据收集于2021至2025年,中位观察期12.0年(IQR 6.4-17.8)。

主要发现

  • 24个月mPERR应答者CKD 4-5D/T无生存率在24个月后1、5、10年分别为100%、98.8%、97.2%,非应答者分别为92.9%、78.6%、78.6%(log-rank P=0.013)。
  • 多变量分析显示24个月mPERR无应答(校正风险比4.39,95%CI 1.04-18.4,P=0.04)和基线eGFR<60 ml/min/1.73m2(校正风险比6.07,95%CI 1.21-30.39,P=0.03)为CKD 4-5D/T预测因素。

临床怎么用

  • 对儿童起病狼疮性肾炎患者,应关注活检后24个月mPERR和mCRR达标情况以评估长期肾脏预后。
  • 24个月mPERR无应答或基线eGFR<60者需加强监测和干预以降低进展至晚期CKD及复发风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The aim of this study was to evaluate the relationship between modified primary efficacy renal response (PERR, mPERR) and modified complete renal response (CRR, mCRR) at 24 months postbiopsy and long-term kidney outcomes in childhood-onset lupus nephritis (LN, cLN). METHODS: We conducted a cohort study of biopsy-proven cLN diagnosed at the age of <18 years between 2001 and 2023, with prospective data collected from 2021 to 2025. We examined the relationship between modified versions of PERR (mPERR) and CRR (mCRR) at 24 months postbiopsy and survival free from advanced chronic kidney disease (CKD), including kidney failure (CKD 4-5D/T). RESULTS: One hundred seven Chinese children (93 female; median age at diagnosis: 13.7, interquartile range [IQR]: 11.0-16.6 years) were analyzed. Ninety-seven (91%) had proliferative LN. The median observation period was 12.0 (IQR: 6.4-17.8) years. At 24 months postbiopsy, 93 (87%) and 81 (76%) subjects were mPERR and mCRR responders, respectively. Kaplan-Meier analysis showed mPERR responders at 24 months had superior CKD 4-5D/T-free survival (responders: 100%, 98.8%, and 97.2%; nonresponders 92.9%, 78.6%, and 78.6% at 1, 5, and 10 years following 24 months postbiopsy; log-rank P = 0.013). Achieving mCRR trended toward better kidney survival. Multivariable analysis identified 24-months mPERR nonresponse (adjusted hazard: 4.39, 95% confidence interval CI: 1.04-18.4, P = 0.04) and baseline estimated glomerular filtration rate (eGFR) < 60 ml/min per 1.73 m2 (adjusted hazard: 6.07, 95% confidence interval: 1.21-30.39, P = 0.03) as predictors of CKD 4-5D/T. Forty-four subjects (41%) experienced 89 kidney relapse episodes. Kaplan-Meier analysis showed that nonresponse by mPERR (log-rank P < 0.001) and mCRR (log-rank P = 0.03) at 24 months were associated with inferior relapse-free survival. CONCLUSION: mPERR at 24 months predicts long-term kidney survival in cLN. Achieving mPERR and mCRR shows significant benefits on lower risk of renal relapse.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Chan EY, Wu KC, Zhou D, et al. Renal Response Status and Long-Term Kidney Outcomes in Childhood-Onset Lupus Nephritis. Kidney Int Rep. 2025. PMID: 41542110. doi:10.1016/j.ekir.2025.11.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。